Business Wire

Global Study: 73% of Shoppers Using AI in Shopping Journey - But Merchants Face New Agentic Commerce Risks

20.10.2025 14:00:00 CEST | Business Wire | Press Release

Share

Riskified (NYSE: RSKD), a global leader in ecommerce fraud prevention and risk intelligence, today released findings from a survey highlighting the increased adoption of agentic shopping, and the rising threat it poses to merchants.

Based on a global survey of more than 5,000 consumers, the research reveals a defining moment for ecommerce: nearly three in four shoppers (73%) are already using AI in their shopping journey. Shoppers are embracing AI assistants like ChatGPT for product ideas (45%), to summarize reviews (37%), and to compare prices (32%). While only 13% say they’ve completed a purchase after being referred by an AI assistant, 70% are at least somewhat comfortable with an AI agent making purchases on their behalf. More than half (58%) are likely to use these tools for gift shopping this year, marking the beginning of the first truly AI-powered holiday season, where convenience for consumers may come with heightened exposure for merchants who may bear the liability for this uncharted domain.

“AI shopping agents may make buying easier for consumers, but they also blur the lines of accountability for fraud and policy abuse,” said Jeff Otto, Chief Marketing Officer at Riskified. “When an AI shopping agent makes a purchase, is the merchant still liable when a dispute occurs - even though the shopper never visited the merchant’s site during checkout? That uncertainty creates new risks for everyone involved. A disputed charge could stem from a hijacked AI account or even a legitimate customer claiming their AI assistant made a mistake. In each case, the liability remains murky, and data transparency is in short supply.”

Fraudsters are poised to leverage advancements in agentic commerce to their end. Already enabled by AI themselves, fraud rings will look to exploit gaps in identity verification, account security, customer service claims, and payment flows. What feels like a smoother shopping experience for consumers can quickly become a surge in disputes and chargebacks, leaving the merchant with costs they will need to absorb. Businesses stand to face significant disadvantages, many of which are reflected in consumers' top concerns.

Payment security is the main worry for nearly one in three shoppers (32%), followed by privacy (26%), potential mistakes (18%), and loss of control (17%). Despite these fears, trust in AI is closing in on traditional channels: 36% of consumers now trust AI to influence their purchases, nearly matching the 38% who rely on in-store associates. Only 25% prefer to shop online without the aid of AI.

Given this evolution in consumer behavior, alongside the rollout of the Agentic Commerce Protocol (ACP), an open standard that enables shoppers to complete purchases through AI interfaces, merchant fraud teams should focus on the following strategic imperatives:

  • Educate executive leadership: Fraud teams are uniquely positioned to understand the risk-reward trade-off of agentic commerce. They must proactively educate their organizations about the new vectors for fraud and abuse to ensure leadership understands the full picture before integrating these new technologies.
  • Advocate for data transparency: For agentic commerce to be a sustainable partnership, technology platforms like OpenAI must share crucial customer behavioral insights - such as the end user's IP address, device information, and behavioral signals - with merchants. Without this visibility, merchants cannot make informed decisions, and fraud and abuse could overwhelm the system.
  • Leverage shared intelligence: In an agentic world where merchants have less direct data, partnering with networked fraud intelligence platforms becomes even more critical. Partnering with Riskified can restore some of the context lost in agentic transactions by connecting data points across a global community of merchants.

Otto stated, “Fraud teams are the natural leaders for agentic commerce safety because they're hardwired to see both the opportunity and the risk. Their expertise isn't about saying 'no' to innovation; it's about building the guardrails that allow the company to say 'yes' confidently. They are essential to ensuring that exciting new channels like this become sustainable revenue drivers, not vectors for fraud and abuse.”

Riskified empowers merchants to thrive in the dynamic world of agentic commerce with innovative tools designed to ensure both growth and security, while providing guarantees to offset financial liability for agentic fraud chargebacks.Read more about our point of view and how Riskified helps merchants embrace this future of ecommerce with confidence.

About the Survey

Riskified conducted an online survey from September through October 2025, sampling 5,400 consumers ages 18 to 64 across multiple markets, with representation from the U.S., U.K., Brazil, Mexico, Singapore, Australia, China, the Netherlands and the UAE. Respondents are consumers who made an online purchase within the last three months.

About Riskified

Riskified (NYSE: RSKD) empowers businesses to unleash ecommerce growth by outsmarting risk. Many of the world’s biggest brands and publicly traded companies selling online rely on Riskified for guaranteed protection against chargebacks, to fight fraud and policy abuse at scale, and to improve customer retention. Developed and managed by the largest team of ecommerce risk analysts, data scientists, and researchers, the Riskified ecommerce risk management platform analyzes the individual behind each interaction to provide real-time decisions and robust identity-based insights. Learn more at www.riskified.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251020127097/en/

Contacts

Corporate Communications:
Cristina Dinozo
Senior Director of Communications
press@riskified.com

Investor Relations:
Chett Mandel
Head of Investor Relations
ir@riskified.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye